Aimmune Longitudinal Collaboration Study
NCT07218640
This study is recruiting at 2 US sites in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
This study will include healthy households around the Irvine, CA area (based local to employees) and Tempe, AZ and Philadelphia, PA sites that will be instructed to take a daily fiber supplement (2.5 tablespoons of chia seeds [~10.3g of fiber] which is one serving) for two months. Participants will use a stool sampling tool to facilitate ease of stool collection, or they may donate at a study site.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Stool Spore Colony Forming Units
- Microbiome Composition
- Dietary Fiber
- Stress
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 18 to 50 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Aimmune Therapeutics, Inc.
- Last updated on ClinicalTrials.gov
- October 20, 2025
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Pennsylvania · 2
- Aimmune Therapeutics Manufacturing · Ambler, PA
- GoodNature Tempe · Ambler, PA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.